Day 1 (17 October 2019) | |
13.00 - 19.00 | Registration |
19.00 - 20.00 | Course presentation |
20.00 - 22.00 | Opening Ceremony |
Day 2 (18 October 2019) | |
08.00 - 09.00 | Registration |
09.00 - 09.20 | Opening by the organizers |
09.20 - 09.30 | Welcome messages |
Parkinson’s disease and DBS anno 2019 | |
Moderators: Yasin Temel, Musa Onar | |
09.30 - 10.00 | Clinics of Parkinson’s disease anno 2019 Mark Janssen |
10.00 - 10.30 | Structural and functional anatomy in Parkinson’s disease anno 2019 Hagai Bergman |
10.30 - 11.00 | Mood and neuropathological changes in Parkinson’s disease |
11.00 - 11.30 | Coffee break |
11.30 - 12.00 | Discussion with lecturers |
Oral abstract and case presentations | |
Moderators: Ahmet Acarer, Zeynep Tüfekçioğlu, Sait Öztürk | |
12.00 - 12.30 | Oral presentations |
OP-01: Statistical Shape Analysis of Subthalamic Nucleus in Patients with Parkinson’s Disease |
|
OP-02: Parkinson’s Disease and Neuromodulation Nursing |
|
OP-03: Effects of Deep Brain Stimulation of the Subthalamic Nucleus on Acoustic Characteristics of Voice Production: Preliminary Results |
|
12.30-13.30 | Lunch |
Emotional symptoms, mechanisms and drug-based approaches in Parkinson’s disease |
|
Moderators: Şükrü Aykol, Okan Doğu, Haşmet Hanağası | |
13.30 - 14.00 | Advances in understanding the emotional disturbances caused by Parkinson’s disease and DBS |
14.00 - 14.30 | The neuronal mechanisms of emotions and cognition Sarah Hescham |
14.30 - 15.00 | Advances in mechanisms of DBS |
15.00 - 15.30 | Drug-based advanced therapies in Parkinson’s disease Raif Çakmur |
15.30 - 16.00 | Coffee break |
16.00 - 16.30 | Discussion with lecturers |
Social conference | |
Moderators: Ersin Erdoğan, Bekir Tuğcu | |
16.30 - 17.30 | Social conference Sezai Sarıoğlu |
Oral abstract and case presentations | |
Moderators: Dursun Aygün, Tanju Uçar, Yeşim Karadağ | |
17.30 - 18.30 | Oral presentations |
OP-04: The Alteration of Neurogenesis and Pathological Markers in Alzheimer’s Disease after Deep Brain Stimulation |
|
OP-05: Medical and Device-Guided Therapies and Deep Brain Stimulation in Parkinson’s Disease: Experience of a Tertiary Centre from Turkey |
|
OP-06: Effect of Subthalamic Nucleus Deep Brain Stimulation on Nutritional Status and Habits in Parkinson's Patients |
|
OP-07: DBS Experiences at Akdeniz University Neuromodulation Unit |
|
OP-08: Deep Brain Stimulation for Movement Disorders: A Single Center Study Involving 135 Nuclei Electrode Implantation without any Intra-Cerebral Hemorrhage |
|
OP-09: Unilateral Globus Pallidus İnterna Deep Brain Stimulation in Post Stroke Dystonic Tremor: Case Report Taha Assadnejad, Behrad Nassehi, Dursun Aygün, Mustafa Onur Yildiz, Ersoy Kocabıçak |
|
Rational Drug Use |
|
18.30 - 19.00 | Rational Drug Use Ersoy Kocabıçak |
Day 3 (19 October 2019) | |
Pathophysiology and contribution of DBS to understanding the disease |
|
Moderators: Erdal Ağar, Cihan İşler | |
09.00 - 09.30 | Advances in understanding the pathophysiology of Parkinson’s disease Cenk Akbostancı |
09.30 - 10.00 | What has DBS contributed to the understanding the neurocircuitry of Parkinson’s disease? |
10.00 - 10.30 | Discussion with lecturers |
10.30 - 11.00 | Coffee break |
Interactive panel | |
Moderator: Murat Emre | |
11.00 - 12.00 | What do neurologists expect from a DBS center? |
12.00 - 13.00 | Lunch |
Oral abstract and case presentations | |
Moderators: Ayşe Bora Tokçaer, Ahmet Bekar, Sibel Özkaynak | |
13.00 - 14.00 | Oral presentations |
OP-10: When İnternal Pulse Generator Should Be Activated Following Deep Brain Stimulation in Parkinson's Disease? |
|
OP-11: Different Problems We Faced With in 2 STN DBS Patients for Parkinson |
|
OP-12: Twiddler Syndrome in Deep Brain Stimulation |
|
OP-13: Long-Term Outcomes of Deep Brain Stimulation in Parkinson Disease: Single Center Experience |
|
OP-14: Impact of Anesthesia in the Microelectrode Recordings During Deep Brain Stimulation for Parkinson Disease Patients |
|
OP-15: Follow-Up Effect of Deep Brain Stimulation of the Thalamic Ventralis İntermedius Nucleus in a Patient with Bipolar Disorder and Essential Tremor |
|
Latest innovations in neuromodulation practice and classical surgical techniques for Parkinson’s disease |
|
![]() |
Moderators: Selçuk Peker, Murat Vural |
14.00 - 14.30 | Stereotactic RF thalamotomy Ali Savaş |
14.30 - 15.00 | Directional steering Ersoy Kocabıçak |
15.00 - 15.30 | Closed loop DBS Mark Janssen |
15.30 - 16.00 | MRI guided Focused USG thalamotomy Cenk Akbostancı |
16.00 - 16.30 | Coffee break |
Oral abstract and case presentations |
|
Moderators: Murat Gültekin, Aykan Ulus | |
16.30 - 17.30 | Oral presentations |
OP-16: Subthalamic Nucleus Deep Brain Stimulation in a Patient with Severe Axial Symptoms and Minimal Levodopa Responsive Parkinson's Disease |
|
OP-17: Neuroacantocytosis with Amyotrophy: Two Cases Diagnosed |
|
OP-18: Expression of Aquaporin-4 Channels in the Mouse Prefrontal Cortex and Hippocampus in MK-801 Induced Schizophrenia-Like Behaviour Model |
|
OP-19: Forced Normalisation: Case Report |
|
OP-20: Robotic Surgical Aprproach to Mesiotemporal Region; Anatomical Study |
|
OP-21: Vagal Nerve Access by Minimally İnvasive Anterior Cervikal Approach with Robotic System; Anatomical Study |
|
17.30 | Closing remarks |